| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2144107 | Lung Cancer | 2006 | 14 Pages |
Abstract
Second-line chemotherapy offers NSCLC patients a small but significant survival improvement. However, this field of clinical research needs further investigations in order to answer certain remaining questions especially concerning targeted therapies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fabrice Barlési, William Jacot, Philippe Astoul, Jean-Louis Pujol,